Apimeds Pharmaceuticals US, Inc. (APUS) — Defensive Interval Ratio
Apimeds Pharmaceuticals US, Inc. (APUS) has a Defensive Interval Ratio of 38 days as of March 2026. Defensive assets of $1.50 Million (cash $-, short-term investments $1.50 Million, receivables $-) cover 38 days of daily cash needs of $39.96K/day. Check Apimeds Pharmaceuticals US, Inc. liquidity resilience to evaluate the company's liquid asset resilience ratio.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Apimeds Pharmaceuticals US, Inc. Defensive Interval Ratio (2025–2025)
This chart shows how Apimeds Pharmaceuticals US, Inc.'s Defensive Interval Ratio has evolved across 1 annual periods from 2025 to 2025. As of March 2026, the ratio stands at 38 days, meaning defensive assets of $1.50 Million can fund 38 days of operations without new revenue. See APUS net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Defensive Interval Ratio for Apimeds Pharmaceuticals US, Inc. (2025–2025)
The table below presents the year-by-year Defensive Interval Ratio for Apimeds Pharmaceuticals US, Inc. from 2025 to 2025, covering 1 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see balance sheet size of Apimeds Pharmaceuticals US, Inc..
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 68 days | $2.00 Million | $29.33K/day | $- | $2.00 Million | — |